Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2

• Shanmei Chen,
• Junnan Feng,
• Chuanke Zhao,
• Lixin Wang,
• Lin Meng,
• Caiyun Liu,
• Shaoqing Cai,
• Yanxing Jia,
• Like Qu,
• Chengchao Shou

Affiliations

Shanmei Chen

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute

Junnan Feng

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute

Chuanke Zhao

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute

Lixin Wang

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute

Lin Meng

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute

Caiyun Liu

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute

Shaoqing Cai

Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University

Yanxing Jia

Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University

Like Qu

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute

Chengchao Shou

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute